target audience: TECH BUYER  Publication date: Dec 2022 - Document type: IDC MarketScape - Doc  Document number: # US48061622

IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment

By:  Nimita Limaye Loading

Content



Related Links

Table of Contents


  • IDC MarketScape Figure

    • Figure: IDC MarketScape Worldwide Life Science R&D Pharmacovigilance Solutions Vendor Assessment

  • IDC Opinion

  • IDC MarketScape Vendor Inclusion Criteria

  • Advice for Technology Buyers

  • Vendor Summary Profiles

    • Accenture

    • Strengths

    • Challenges

    • Consider Accenture When

    • ArisGlobal

    • Strengths

    • Challenges

    • Consider ArisGlobal When

    • Cognizant

    • Strengths

    • Challenges

    • Consider Cognizant When

    • Indegene

    • Strengths

    • Challenges

    • Consider Indegene When

    • IQVIA

    • Strengths

    • Challenges

    • Consider IQVIA When

    • Navitas Life Sciences

    • Strengths

    • Challenges

    • Consider Navitas Life Sciences When

    • Oracle

    • Strengths

    • Challenges

    • Consider Oracle When

    • PwC

    • Strengths

    • Challenges

    • Consider PwC When

    • Sarjen Systems

    • Strengths

    • Challenges

    • Consider Sarjen Systems When

    • TCS

    • Strengths

    • Challenges

    • Consider TCS When

    • Veeva

    • Strengths

    • Challenges

    • Consider Veeva When

    • Vendors to Watch

  • Appendix

    • Reading an IDC MarketScape Graph

    • IDC MarketScape Methodology

    • Market Definition

    • Market Overview

    • Strategies and Capabilities Criteria

    • Table: Key Strategy Measures for Success: Worldwide Life Science R&D Pharmacovigilance Solutions

    • Table: Key Capability Measures for Success: Worldwide Life Science R&D Pharmacovigilance Solutions

  • Learn More

    • Related Research

    • Synopsis